GlassScriptPhysician profile
Suzanne Mariano
NPI 1518553700
$1,985.26
in general payments reported to CMS, 2019-2025
20 companies · $98.80 in 2025
The $98.80 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $499 · 2022: $394 · 2023: $608 · 2024: $385 · 2025: $98.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,092.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,092.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $457.47 | 2021-2023 | Jardiance, Tradjenta |
| Novo Nordisk INC | $260.97 | 2023-2024 | Ozempic, Rybelsus, Wegovy |
| Otsuka America Pharmaceutical, INC. | $240.53 | 2021-2024 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $125.61 | 2021-2023 | Trintellix |
| Lundbeck LLC | $124.71 | 2023-2024 | Rexulti |
| Merck Sharp & Dohme LLC | $110.56 | 2021 | |
| Sk Life Science, INC. | $98.80 | 2025 | |
| Lilly USA, LLC | $84.51 | 2023-2024 | Jardiance, Zepbound, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $81.40 | 2023-2024 | Fasenra, Breztri |
| E.R. Squibb & Sons, L.L.C. | $76.11 | 2022-2024 | Eliquis, Camzyos |
| Kowa Pharmaceuticals America, INC. | $55.42 | 2021 | |
| Pfizer INC. | $52.61 | 2022-2023 | |
| Glaxosmithkline, LLC. | $46.09 | 2023 | Arexvy, Shingrix |
| Antares Pharma, INC. | $42.01 | 2021-2022 | |
| Abbvie INC. | $28.80 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $24.32 | 2021 | |
| Xeris Pharmaceuticals, INC. | $23.50 | 2023 | Recorlev |
| Lantheus Medical Imaging, INC. | $19.29 | 2021 | |
| Medtronic, INC. | $18.51 | 2021 | |
| Ibsa Pharma INC. | $14.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Mariano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.